Compare SWBI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SWBI | CYRX |
|---|---|---|
| Founded | 1852 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.2M | 419.3M |
| IPO Year | 2000 | 2008 |
| Metric | SWBI | CYRX |
|---|---|---|
| Price | $14.84 | $9.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $14.00 | $12.94 |
| AVG Volume (30 Days) | ★ 622.2K | 406.1K |
| Earning Date | 03-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | 0.05 | ★ 1.40 |
| Revenue | ★ $474,661,000.00 | $176,177,000.00 |
| Revenue This Year | $7.61 | $11.06 |
| Revenue Next Year | $3.72 | $8.45 |
| P/E Ratio | $293.00 | ★ $6.89 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.73 | $5.21 |
| 52 Week High | $15.40 | $11.45 |
| Indicator | SWBI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 70.69 |
| Support Level | $13.65 | $9.18 |
| Resistance Level | $15.40 | $10.23 |
| Average True Range (ATR) | 0.46 | 0.42 |
| MACD | -0.10 | 0.19 |
| Stochastic Oscillator | 59.11 | 88.01 |
Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.